Prediction of anti-CD25 and 5-FU treatments efficacy for pancreatic cancer using a mathematical model

Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with rising incidence and with 5-years overall survival of less than 8%. PDAC creates an immune-suppressive tumor microenvironment to escape immune-mediated eradication. Regulatory T (Treg) cells and myeloid-deriv...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sajad Shafiekhani, Hojat Dehghanbanadaki, Azam Sadat Fatemi, Sara Rahbar, Jamshid Hadjati, Amir Homayoun Jafari
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
GUI
ODE
Accès en ligne:https://doaj.org/article/a2604ce40f084ba89a35729eb57b16c3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!